Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket

Author: Lisa Levin | October 14, 2022 07:34am

Gainers

• Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private placement.
• Zovio Inc (NASDAQ:ZVO) rose 16.8% to $0.1690 in pre-market trading.
• Eargo, Inc. (NASDAQ:EAR) rose 16.5% to $0.8269 in pre-market trading. Eargo announced that the record date for its proposed rights offering is October 24, 2022.
• FedNat Holding Company (NASDAQ:FNHC) rose 16.3% to $0.4089 in pre-market trading after jumping over 56% on Thursday.
• IMARA Inc. (NASDAQ:IMRA) rose 13.2% to $2.92 in pre-market trading. Enliven Therapeutics and Imara announced a merger agreement.
• Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares rose 10.3% to $2.68 in pre-market trading after declining over 4% on Thursday.
• WM Technology, Inc. (NASDAQ:MAPS) shares rose 9.9% to $1.88 in pre-market trading.
• Quanergy Systems, Inc. (NYSE:QNGY) shares rose 9.3% to $2.00 in pre-market trading after dipping 16% on Thursday.
• CarLotz, Inc. (NASDAQ:LOTZ) rose 8% to $0.29 in pre-market trading.
• Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) rose 7.7% to $3.47 in pre-market trading.
• Digital Brands Group, Inc. (NASDAQ:DBGI) shares rose 7.3% to $0.1180 in pre-market trading after the company finalizes new agreement for $20 million revenue Sunnyside, LLC acquisition, scheduled to close in November.
• Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) rose 7.1% to $1.36 in pre-market trading after declining over 5% on Thursday.
• Zai Lab Limited (NASDAQ:ZLAB) rose 6% to $30.20 in pre-market trading. Seagen and Zai Lab recently announced an exclusive collaboration and license agreement for the development and commercialization of TIVDAK (tisotumab vedotin-tftv) in mainland China, Hong Kong, Macau, and Taiwan.

Don’t forget to check out our premarket coverage here .

Losers

• Novo Integrated Sciences, Inc. (NASDAQ:NVOS) fell 38.7% to $0.46 in pre-market trading after the company announced pricing of $2 million public offering of 4 million units at $0.50 per unit.
• Nuwellis, Inc. (NASDAQ:NUWE) fell 13.3% to $0.2880 in pre-market trading after dropping 10% on Thursday. Nuwellis recently announced results of the AVOID-HF clinical study analysis at the 2022 HFSA meeting, showing a "statistically superior clinical benefit of Aquadex therapy in reducing heart failure events and mortality."
• Nutex Health Inc. (NASDAQ:NUTX) fell 10.8% to $0.8512 in pre-market trading after jumping 72% on Thursday. Nutex recently provided a corporate update.
• Gravitas Education Holdings, Inc. (NYSE:GEHI) shares fell 9.2% to $13.62 in pre-market trading after surging around 14% on Thursday.
• Romeo Power, Inc. (NYSE:RMO) shares fell 8.7% to $0.33 in pre-market trading. Nikola completed exchange offer to acquire Romeo Power common stock.
• Oblong, Inc. (NASDAQ:OBLG) shares fell 7.7% to $0.2123 in pre-market trading after climbing over 26% on Thursday.
• Qualigen Therapeutics, Inc (NASDAQ:QLGN) fell 7.1% to $0.2510 in pre-market trading.
• Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 6.7% to $0.4750 in pre-market trading. JonesTrading, last week, initiated coverage on the stock with a Buy rating and $5 price target.
• China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares fell 6.6% to $0.6180 in pre-market trading. On October 11, China SXT Pharmaceuticals received the funds from Mr. Xiao who previously agreed to purchase 1,625,798 shares of the company, par value $0.08/share at a per share purchase price of $1.35.

Posted In: ATXI BDTX CNXA DBGI EAR FNHC GEHI IMRA LOTZ MAPS NUTX NUWE NVOS OBLG PSTV QLGN QNGY RMO SHPH SXTC